Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Ontuxizumab Biosimilar – Anti-CD248 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Ontuxizumab Biosimilar - Anti-CD248 mAb - Research Grade |
|---|---|
| Source | CAS 946415-62-9 |
| Species | Chimeric,Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Ontuxizumab,MORAb-004,CD248,anti-CD248 |
| Reference | PX-TA1346 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Ontuxizumab Biosimilar - Anti-CD248 mAb - Research Grade
General information on Anti-CD248[Homo sapiens] (Ontuxizumab) Monoclonal Antibody
Ontuxizumab monoclonal antibody targets CD248. It has been used in the treatment of cancer.
Related products
Antigen
CD2 Recombinant Protein
PX-P4073 420€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.